ReachMD
Be part of the knowledge.™CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 586-600 of 631
Maximizing PH Care Using Risk Assessment to Improve Outcomes
CME/CE Broadcast ReplayMaximizing PH Care Using Risk Assessment to Improve Outcomes
New Horizons in the Medical Management of Endometriosis: The Role of GnRH Antagonists: A “Voice of Patient/Voice of Provider” Curriculum
CME/CENew Horizons in the Medical Management of Endometriosis: The Role of GnRH Antagonists: A “Voice of Patient/Voice of Provider” Curriculum
How Can You Recognize and Manage the Common Adverse Events Seen With ADCs?
Minute CME/CE™How Can You Recognize and Manage the Common Adverse Events Seen With ADCs?
Expert Panel: Real-World Experience With ADCs in TNBC
Minute CME/CE™Expert Panel: Real-World Experience With ADCs in TNBC
Disparities in TNBC: Screening, Diagnosis, and Management: A Panel Discussion
Minute CME/CE™Disparities in TNBC: Screening, Diagnosis, and Management: A Panel Discussion
What Is the Evidence Supporting TROP-2 Directed Therapy in Current Clinical Practice of Patients With TNBC?
Minute CME/CE™What Is the Evidence Supporting TROP-2 Directed Therapy in Current Clinical Practice of Patients With TNBC?
What Is the Therapeutic Rationale for ADCs in Cancer?
Minute CME/CE™What Is the Therapeutic Rationale for ADCs in Cancer?
Why Is TROP2-Directed Antibody Therapy Important in Breast Cancer?
Minute CME/CE™Why Is TROP2-Directed Antibody Therapy Important in Breast Cancer?
Expert Panel: Integrating and Optimizing ADCs In the Treatment of TNBC
Minute CME/CE™Expert Panel: Integrating and Optimizing ADCs In the Treatment of TNBC
Case Discussion: How Do I Manage Patients With TNBC?
Minute CME/CE™Case Discussion: How Do I Manage Patients With TNBC?
How Do I Optimize GDMT with New Therapies in My Patients Following a Worsening HF Event?
CME/CEHow Do I Optimize GDMT with New Therapies in My Patients Following a Worsening HF Event?
Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide
CME/CEFactors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide
